Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US09062X1037
Ticker BIIB
Company BIOGEN
Currency $
Price
Aware Investor Index (AII) 3.2564
Recommendation BUY
P/E 19.86
ROE 18.10 %
Capitalization 46,890,520,000 $
Dividend Yield 0.00 %
P/S 3.49
AII Position 167
P/E Position 270
ROE Position 183
Capitalization Position 198
Dividend Yield Position 594
Sales 13,452,900,000 $
10-Year Average Earnings 2,360,650,000 $
Shares Outstanding 205,300,000
Equity 13,039,600,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
BIOGEN Investor Relations Web Site http://investors.biogen.com/investor-relations







Sales:

YEAR MONTH AMOUNT
2018 12 13,452,900,000.00 $
2017 12 12,273,900,000.00 $
2016 12 11,448,800,000.00 $
2015 12 10,763,800,000.00 $
2014 12 9,703,300,000.00 $
2013 12 6,932,200,000.00 $
2011 12 5,516,500,000.00 $
2010 12 5,048,600,000.00 $
2009 12 4,716,400,000.00 $
2008 12 4,377,300,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 4,430,700,000.00 $
2017 12 2,539,100,000.00 $
2016 12 3,702,800,000.00 $
2015 12 3,547,000,000.00 $
2014 12 2,934,800,000.00 $
2013 12 1,862,300,000.00 $
2012 12 1,380,000,000.00 $
2011 12 1,234,400,000.00 $
2010 12 1,005,300,000.00 $
2009 12 970,100,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 13,039,600,000.00 $
2017 12 12,612,800,000.00 $
2016 12 12,140,000,000.00 $
2015 12 9,372,800,000.00 $
2014 12 10,809,000,000.00 $
2013 12 8,620,200,000.00 $
2012 12 6,961,500,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 205,300,000
2017 12 213,000,000
2016 12 218,800,000
2015 12 231,200,000
2014 12 237,200,000
2013 12 238,300,000
2012 12 239,700,000

 












Bloomberg News for BIOGEN:



Google News for BIOGEN:

Stocks Beat - 1 day ago
As Biogen (BIIB) Market Value Declined, Terril Brothers Has Cut by ...
Terril Brothers Inc decreased its stake in Biogen Inc (BIIB) by 4.85% based on its latest 2019Q1 regulatory filing with the SEC. Terril Brothers Inc ...
Wagner Review - 5 hours ago
Biogen Inc. (BIIB) Quant Signal Reaches 881
Biogen Inc. (BIIB) has an ERP5 rank of 881. The ERP5 score was designed by the MFIE Capital team. It combines the Greenblatt Magic formula ...
The News Heater
Biogen Inc. (NASDAQ:BIIB) Insiders Increased Their Holdings
So before you buy or sell Biogen Inc. (NASDAQ:BIIB), you may well want to know whether insiders have been buying or selling.
The Dwinnex
Biogen (BIIB) Outpaces Stock Market Gains: What You Should Know
Biogen (BIIB) closed at $227.33 in the latest trading session, marking a +1.33% move from the prior day. This move outpaced the S&P 500's ...
Stocks Beat
Biogen (BIIB) Gains But Lags Market: What You Should Know
In the latest trading session, Biogen (BIIB) closed at $230.86, marking a +0.19% move from the previous day. The stock lagged the S&P 500's ...
Yahoo Finance - 5 days ago
Biogen (BIIB) Dips More Than Broader Markets: What You Should ...
Biogen (BIIB) closed the most recent trading day at $223.40, moving -0.95% from the previous trading session. This change lagged the S&P ...
Seeking Alpha
Is Biogen Inc. (BIIB) A Good Stock To Buy?
Biogen Inc. (NASDAQ:BIIB) was in 49 hedge funds' portfolios at the end of the first quarter of 2019. BIIB has experienced a decrease in hedge ...
US Post News
Biogen Com (BIIB) Shares Declined While Clean Yield Group Has ...
Clean Yield Group increased its stake in Biogen Inc Com (BIIB) by 40.83% based on its latest 2019Q1 regulatory filing with the SEC. Clean ...
Stocks Beat
Biogen Com Stk (BIIB) Holder Sivik Global Healthcare Lowered ...
Sivik Global Healthcare Llc decreased its stake in Biogen Inc Com Stk (BIIB) by 25% based on its latest 2019Q1 regulatory filing with the SEC.
Yahoo Finance - 7 Jun 2019
Massmutual Trust Company Fsb Raised Its Holding in Biogen (BIIB ...
Massmutual Trust Company Fsb increased its stake in Biogen Inc (BIIB) by 2.11% based on its latest 2019Q1 regulatory filing with the SEC.


Back